Laboratory Manager - RA
Adelaide Medical School
Faculty of Health and Medical Sciences
Vicky is currently enrolled as a PhD student within the Neuroimmunopharmacology Laboratory (School Medicine/ Faculty Health Sciences), headed by supervisor Prof. Mark Hutchinson. Vicky is also a member of the ARC Centre of Excellence for Nanoscale Biophotonics (Origins of Sensations biological theme).
Title of her PhD research project is: The role of nitroxyl (HNO) in neuropathic pain signalling and development of morphine tolerance.
Vicky also currently holds a part-time position as Laboratory Manager/Research Assistant within the same lab, and prior to starting her PhD,worked in a similar capacity within various labs from the Universities of Adelaide and Melbourne for the last 16 years.
Is the development of neuropathic pain and/or the loss of analgesic effects of morphine dependent upon the concentrations of central nitric oxide and nitroxyl, and are these effects mediated by the TLR4 receptor pathway?
- Neuropathic pain, the most diagnosed type of chronic pain in Australia affects approximately 7% of the population with highest prevalence in patients aged 45-64 and sex difference varying depending on the underlying disease state (Pollack, A, et al., 2013). The total cost of chronic pain to the Australian economy was reported to be $34 billion, including $7 billion in health system costs (Access Economics, 2007).
- Neuropathic pain is defined as pain caused by a lesion of the peripheral or central nervous system (CNS) and can develop either post-surgically or from a variety of disease states ranging from diabetic neuropathy through to post-traumatic spinal cord injury. It is characterized by the presence of allodynia (pain generated from non-noxious stimuli) and hyperalgesia (heightened sense of pain to noxious stimuli) with patients frequently presenting with symptoms such as burning pain, stabbing pain or pins and needles.
- Pain normally serves to guard against tissue injury, as it is imperative that the body is aware of potentially damaging stimuli. It also allows us to protect the damaged area as to facilitate tissue repair after injury.
- Neuropathic pain is a type of pathophysiological chronic pain state, and unlike other types of chronic pain such as nociceptive or inflammatory pain, is maladaptive, therefore neither protects or supports healing or repair (Costigan M, et al., 2009).
NITROGEN SPECIES AND PAIN
Nitric Oxide production Nitroxyl production: DOI: 10.1016/j.niox.2016.04.006
Nitric oxide is able to act as a neurotransmitter following neuronal generation and release to signal during neuropathic pain, however it also acts via a neuronal- glial pathway with glial cells also able to produce nitric oxide in large amounts contributing to the development and maintenance of neuropathic pain.
Nitroxyl, the protonated form of nitric oxide has also been implicated in neuropathic pain signalling, however the endogenous role has yet to be determined. Recently, Longhi-Balbinot et al (2016), demonstrated that administration of HNO donor was able to reduce pain sensitivity (hyperalgesia) by reducing the reactivity of spinal glia and expression of their associated cytokines.
To be continued......Work in progress..........
Date Position Institution name 2011 Research Associate University of Adelaide 2003 - 2010 Research Assistant University of Melbourne 1999 - 2003 Research Assistant University of Adelaide
Language Competency Greek, Modern (1453-) Can read, write, speak and understand spoken
Date Institution name Country Title 2016 University of Adelaide Australia PhD 2003 - 2004 Monash University Australia Graduate Certificate - Secondary Education 1997 - 2000 University of Adelaide Australia BSc (Honours)
Year Citation 2016 Staikopoulos, V., Gosnell, M., Anwer, A., Mustafa, S., Hutchinson, M., & Goldys, E. (2016). Hyperspectral imaging of endogenous fluorescent metabolic molecules to identify pain states in central nervous system tissue. In M. Hutchinson, & E. Goldys (Eds.), Proceedings of SPIE - The International Society for Optical Engineering Vol. 10013 (pp. 1-8). Adelaide, AUSTRALIA: SPIE-INT SOC OPTICAL ENGINEERING.
2015 Dodds, K., Beckett, E., Staikopoulos, V., Evans, S., & Hutchinson, M. (2015). Novel mouse model of endometriosis permits identification of spinal glia and nociception characteristics involved in pelvic pain. In JOURNAL OF NEUROCHEMISTRY Vol. 134 (pp. 267). Cairns, AUSTRALIA: WILEY-BLACKWELL. 2015 Staikopoulos, V., Jin, D., Lu, Y., Gibson, B., Reineck, P., Goldys, E., . . . Hutchinson, M. (2015). Ultra-structural imaging in cleared mouse cns using nanoparticles. In JOURNAL OF NEUROCHEMISTRY Vol. 134 (pp. 382). Cairns, AUSTRALIA: WILEY-BLACKWELL. 2015 Jacobsen, J., Staikopoulos, V., & Hutchinson, M. (2015). Optimisation and utilisation of a novel whole-brain imaging technique (clarity) to analyse addiction-like behaviours. In JOURNAL OF NEUROCHEMISTRY Vol. 134 (pp. 351). Cairns, AUSTRALIA: WILEY-BLACKWELL.
Connect With Me